ArticleMolecular biomedicine2025

Disrupting the SHOC2-RAS Nexus: a new frontier in targeting RAS-Driven cancers.

Yudi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.